You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Digestive Remedies in the US

Feb 2011

Price: $900

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Digestive Remedies industry in USA with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Digestive Remedies industry in USA, our research will save you time and money while empowering you to make informed, profitable decisions.

The Digestive Remedies in USA market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Digestive Remedies in USA?
  • What are the major brands in USA?
  • Are there any herbal/traditional home-made digestive remedies, like charcoal, which compete strongly with standard medicinal products?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

TRENDS

  • In 2010, competition between major players in indigestion and heartburn categories intensified dramatically. The battle to win consumers stemmed from two Rx-to-OTC switches within proton pump inhibitors (PPIs) within a span of only five months. In November 2009, Novartis launched Prevacid 24hr and supported it with the largest advertising campaign in the company’s history. Schering-Plough followed by releasing its own Rx-to-OTC PPI – Zegerid OTC – in April 2010. Expectations were high for both products. Prevacid’s massive pre-switch prescription base led to estimates of the brand breaking US$200 million in annual sales in its first year, while Zegerid’s smaller Rx base led to estimates of around US$100 million for first-year sales. The threat of these giant new brands and their advertising led previously established players in related categories to retaliate with new advertising campaigns of their own. Procter & Gamble’s Prilosec – the first PPI to switch from Rx-to-OTC – launched a new advertising initiative, and other antacids like Tums followed suit. In fact, this intensified competition drove advertising spend to record-levels in 2010.

COMPETITIVE LANDSCAPE

  • Procter & Gamble remained the leader in digestive remedies with its major brands like Pepto-Bismol, Metamucil and Prilosec, retaining an overall value share of 17% in 2010. GlaxoSmithKline, led by its Tums brand, held the second overall rank in the category with an 8% value share in 2010. Third-ranked in 2010 was McNeil with a 7% value share held through major brands like Imodium, Rolaids and Lactaid.

PROSPECTS

  • Digestive remedies should continue to be shaped by the development of the PPI category. The intense competition for customers from the three major branded PPIs (Prilosec, Prevacid and Zegerid) should continue to drive high levels of advertising and push sales upwards. In addition, there is a possibility that Pfizer’s Protonix and Eisai’s Aciphex – two other PPIs – could go through an Rx-to-OTC switch in the future. These potential switches stand to bring more consumers into the PPI category and drive sales even further. Finally, PPIs could see a bigger boost from healthcare reform in the US in 2010. As millions of previously uninsured Americans gain access to healthcare, many will see a doctor about heartburn instead of just taking traditional antacid products. As PPI sales are driven largely by doctor recommendations, an increase in visits to doctors should translate into higher rates of PPI usage to treat frequent heartburn. For all of these reasons, Euromonitor International forecasts constant value growth of 16% over 2010-2015 for the PPI category. This growth could be even higher; however, the rapid growth of cheaper private label PPIs threatens to erode value sales. Many retailers have begun to offer omeprazole PPIs as part of their private label product lines. A similar fate is also likely for lansoprazole (Prevacid) in the near future. Private label already holds a 25% value share of the category, a share that will likely grow quite rapidly over the forecast period.

Table of Contents

Table of Contents

Digestive Remedies in the US - Category Analysis

HEADLINES

TRENDS

  • In 2010, competition between major players in indigestion and heartburn categories intensified dramatically. The battle to win consumers stemmed from two Rx-to-OTC switches within proton pump inhibitors (PPIs) within a span of only five months. In November 2009, Novartis launched Prevacid 24hr and supported it with the largest advertising campaign in the company’s history. Schering-Plough followed by releasing its own Rx-to-OTC PPI – Zegerid OTC – in April 2010. Expectations were high for both products. Prevacid’s massive pre-switch prescription base led to estimates of the brand breaking US$200 million in annual sales in its first year, while Zegerid’s smaller Rx base led to estimates of around US$100 million for first-year sales. The threat of these giant new brands and their advertising led previously established players in related categories to retaliate with new advertising campaigns of their own. Procter & Gamble’s Prilosec – the first PPI to switch from Rx-to-OTC – launched a new advertising initiative, and other antacids like Tums followed suit. In fact, this intensified competition drove advertising spend to record-levels in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Procter & Gamble remained the leader in digestive remedies with its major brands like Pepto-Bismol, Metamucil and Prilosec, retaining an overall value share of 17% in 2010. GlaxoSmithKline, led by its Tums brand, held the second overall rank in the category with an 8% value share in 2010. Third-ranked in 2010 was McNeil with a 7% value share held through major brands like Imodium, Rolaids and Lactaid.

PROSPECTS

  • Digestive remedies should continue to be shaped by the development of the PPI category. The intense competition for customers from the three major branded PPIs (Prilosec, Prevacid and Zegerid) should continue to drive high levels of advertising and push sales upwards. In addition, there is a possibility that Pfizer’s Protonix and Eisai’s Aciphex – two other PPIs – could go through an Rx-to-OTC switch in the future. These potential switches stand to bring more consumers into the PPI category and drive sales even further. Finally, PPIs could see a bigger boost from healthcare reform in the US in 2010. As millions of previously uninsured Americans gain access to healthcare, many will see a doctor about heartburn instead of just taking traditional antacid products. As PPI sales are driven largely by doctor recommendations, an increase in visits to doctors should translate into higher rates of PPI usage to treat frequent heartburn. For all of these reasons, Euromonitor International forecasts constant value growth of 16% over 2010-2015 for the PPI category. This growth could be even higher; however, the rapid growth of cheaper private label PPIs threatens to erode value sales. Many retailers have begun to offer omeprazole PPIs as part of their private label product lines. A similar fate is also likely for lansoprazole (Prevacid) in the near future. Private label already holds a 25% value share of the category, a share that will likely grow quite rapidly over the forecast period.

CATEGORY DATA

  • Table 1 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 2 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 3 Digestive Remedies Company Shares by Value 2006-2010
  • Table 4 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 5 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in the US - Company Profiles

Bayer Corp - Consumer Health - USA

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 2 Bayer Corp: Competitive Position 2010

Chattem Inc - Consumer Health - USA

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Chattem Inc: Competitive Position 2010

GlaxoSmithKline Consumer Health - Consumer Health - USA

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 GlaxoSmithKline Consumer Health: Competitive Position 2010

McNeil Consumer & Specialty Pharmaceuticals - Consumer Health - USA

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2010

Pfizer Consumer Healthcare Inc - Consumer Health - USA

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Pfizer Consumer Healthcare Inc: Competitive Position 2010

Wal-Mart Stores Inc - Consumer Health - USA

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Wal-Mart Stores: Competitive Position 2010

Consumer Health in the US - Industry Context

EXECUTIVE SUMMARY

Consumer health industry remains vital

Market leader hit by series of product recalls

Private label growth continues

In-store clinics help drive retail sales

Challenges threaten future industry growth

KEY TRENDS AND DEVELOPMENTS

Johnson & Johnson initiates a series of major product recalls

Debate surrounds the abuse potential of major drugs

US passes landmark healthcare reform law

Ageing population drives growth through OTC, vitamins and dietary supplements and sports nutrition

Retail health clinics continue to grow

MARKET INDICATORS

  • Table 7 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 8 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 9 Sales of Consumer Health by Category: Value 2005-2010
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 11 Consumer Health Company Shares by Value 2006-2010
  • Table 12 Consumer Health Brand Shares by Value 2007-2010
  • Table 13 Penetration of Private Label by Category 2005-2010
  • Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

  • Summary 14 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 15 Research Sources

Segmentation

Segmentation

This market research report includes the following:

  • OTC
    • Adult Mouth Care
    • Analgesics
      • Systemic Analgesics
        • Adult Analgesics
          • Acetaminophen
          • Aspirin
          • Combination Products - Analgesics
          • Diclofenac
          • Dipyrone
          • Ibuprofen
          • Ketoprofen
          • Naproxen
        • Child-Specific Analgesics
          • Child-Specific Acetaminophen
          • Child-Specific Aspirin
          • Child-Specific Combination Products - Analgesics
          • Child-Specific Diclofenac
          • Child-Specific Dipyrone
          • Child-Specific Ibuprofen
          • Child-Specific Ketoprofen
          • Child-Specific Naproxen
      • Topical Analgesics/Anaesthetic
    • Calming and Sleeping
    • Cough, Cold and Allergy (Hay Fever) Remedies
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
      • Cough Remedies
      • Decongestants
        • Nasal Sprays
        • Oral Decongestants
        • Inhalant Decongestants
        • Decongestant Rubs
        • Nasal Decongestant Drops
        • Nasal Decongestant Plasters
      • Medicated Confectionery
      • Pharyngeal Preparations
    • Digestive Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Diarrhoeal Remedies
      • IBS Treatments
      • Indigestion and Heartburn Remedies
        • Antacids
        • Antiflatulents
        • Digestive Enzymes
        • H2 Blockers
        • Proton Pump Inhibitors
      • Laxatives
      • Motion Sickness Remedies
    • Ear Care
    • Emergency Contraception
    • Eye Care
      • Allergy Eye Care
      • Standard Eye Care
    • Medicated Skin Care
      • Acne Treatments
      • Medicated Shampoos
      • Topical Antifungals
      • Vaginal Antifungals
      • Hair Loss Treatments
      • Nappy (Diaper) Rash Treatments
      • Antiparasitics/Lice (Head and Body) Treatments
      • Antipruritics
      • Child-Specific Medicated Skin Care
      • Cold Sore Treatments
      • Haemorrhoid Treatments
      • Topical Allergy Remedies/Antihistamines
      • Topical Germicidals/Antiseptics
    • NRT Smoking Cessation Aids
      • NRT Gum
      • NRT Inhalators
      • NRT Lozenges
      • NRT Patches
      • Other NRT
    • OTC Triptans
    • Wound Care
      • First Aid Kits
      • Sticking Plasters/Adhesive Bandages
      • Gauze, Tape and Other Wound Care

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market Sizes
  • Company Shares
  • Brand Shares
  • Distribution
  • Analysis by Format
  • Analysis by Type
  • Herbal/Traditional vs Standard
  • Pricing

Market size details:

  • Retail Volume
  • Retail Volume % growth
  • Retail Volume per capita
  • Retail Value retail selling price % growth
  • Retail Value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value retail selling price real (constant 2008) Prices % growth
  • Retail Value retail selling price real (constant 2008) Prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value retail selling price real (constant 2008) Prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value manufacturer selling price % growth
  • Retail Value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value manufacturer selling price real (constant 2008) Prices % growth
  • Retail Value manufacturer selling price real (constant 2008) Prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value manufacturer selling price real (constant 2008) Prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value retail selling price Nominal (Current) Prices % growth
  • Retail Value retail selling price Nominal (Current) Prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value retail selling price Nominal (Current) Prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value manufacturer selling price Nominal (Current) Prices % growth
  • Retail Value manufacturer selling price Nominal (Current) Prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail Value manufacturer selling price Nominal (Current) Prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?